Steven L. Hoerter
Steven L. Hoerter occupies the position of President, Chief Executive Officer & Director at Deciphera Pharmaceuticals, Inc. and President, Director & Chief Executive Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.). Steven L. Hoerter is also on the board of Oric Pharmaceuticals, Inc.
In the past he held the position of Chief Commercial Officer at Agios Pharmaceuticals, Inc., Chief Commercial Officer & Executive VP of Clovis Oncology, Inc., Director-Pipeline Development at Genentech, Inc. and GM, Head-Sub-Saharan Africa & Indian Ocean Region at Roche Group.
Steven L. Hoerter received an undergraduate degree from Bucknell University, an MBA from the University of Tilburg and a graduate degree from Purdue University.
|03/18/2021||2,450||Derivative/Non-derivative trans. at $43.19 per share.||105,816|
|03/18/2021||700||Derivative/Non-derivative trans. at $42.39 per share.||29,673|
|01/21/2021||1,078||Derivative/Non-derivative trans. at $25.4 per share.||27,381|
|08/20/2020||187||Derivative/Non-derivative trans. at $25.4 per share.||4,749|
|07/20/2020||188||Derivative/Non-derivative trans. at $25.4 per share.||4,775|
|06/18/2020||187||Derivative/Non-derivative trans. at $25.4 per share.||4,749|
|05/28/2020||188||Derivative/Non-derivative trans. at $25.4 per share.||4,775|
|04/21/2020||187||Derivative/Non-derivative trans. at $25.4 per share.||4,749|
|03/19/2020||520||Derivative/Non-derivative trans. at $39.98 per share.||20,790|
|03/19/2020||2,164||Derivative/Non-derivative trans. at $39.22 per share.||84,873|
|03/19/2020||4,230||Derivative/Non-derivative trans. at $38.26 per share.||161,840|
|03/19/2020||1,012||Derivative/Non-derivative trans. at $36.88 per share.||37,323|
|03/19/2020||4,494||Derivative/Non-derivative trans. at $35.78 per share.||160,796|
|03/18/2020||2,250||Derivative/Non-derivative trans. at $25.4 per share.||57,150|